Diabetes & Vascular Disease Research

Papers
(The median citation count of Diabetes & Vascular Disease Research is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
The role of high mobility group box-1 on the development of diabetes complications: A plausible pharmacological target49
The association between osteoprotegerin and arterial stiffness in a 10-year longitudinal study of patients with type 2 diabetes33
Progression of insulin resistance in individuals with type 1 diabetes: A retrospective longitudinal study on individuals from Thailand30
Longitudinal profiling and tracking stability in the Singapore study of macro-angiopathy and microvascular reactivity in type 2 diabetes cohort29
Corrigendum to “Unraveling the causal role of sleep traits in development of diabetic retinopathy: A UK Biobank observational study and Mendelian randomization”26
Serum microRNAs: A potential blood-based diagnostic biomarkers for diabetic kidney disease in Emirati patients with type 2 diabetes19
MicroRNA-451a downregulation in liraglutide-treated individuals with diabetes: A potential cardiovascular protective mechanism18
Disruption of COMMD1 accelerates diabetic atherosclerosis by promoting glycolysis17
Predictive value of lncRNA DBH-AS1 for cardiovascular events in patients with type 2 diabetes mellitus with coronary heart disease16
Plasma proteomics reveals an improved cardio-metabolic profile in patients with type 2 diabetes post-liraglutide treatment16
Association of hemoglobin glycation index with prognosis of coronary artery disease after percutaneous coronary intervention: A retrospective cohort study14
Use of flash glucose monitoring is associated with HbA1c reduction in type 2 diabetes managed with basal insulin in Canada: A real-world prospective observational study14
RNA-based diagnostic innovations: A new frontier in diabetes diagnosis and management14
“Arterial stiffness is not associated with changes in the circadian pattern of blood pressure in patients with type 1 diabetes mellitus and cardiovascular autonomic dysfunction”13
Coronary artery calcium score and coronary computed tomography angiography predict one-year mortality in patients with type 2 diabetes and peripheral artery disease undergoing partial foot amputation12
Molecular mechanisms of diabetic heart disease: Insights from transcriptomic technologies12
High serum Bhlhe40 levels are associated with subclinical atherosclerosis in patients with type 2 diabetes mellitus: A cross-sectional study12
Health care registers can be instrumental for endpoint capture in clinical diabetes trials: example of microvascular complications in Swedish patients with type 2 diabetes11
Lipoprotein (a) as a predictor of diabetic retinopathy in patients with type 2 diabetes: A systematic review11
TyG-BMI and hypertension in Normoglycemia subjects in Japan: A cross-sectional study11
Trends in cardiovascular burden and mortality among adults with prediabetes in the US, 1999–201810
Temporal trends in minor and major lower extremity amputation in people with type 2 diabetes: The Fremantle Diabetes Study10
Ten-year incidence of post-transplant Diabetes Mellitus in renal transplant patients10
Cardiometabolic risk factors, peripheral arterial tonometry and metformin in adults with type 1 diabetes participating in the REducing with MetfOrmin Vascular Adverse Lesions trial10
Epicardial adipose tissue and right ventricular function in type 2 diabetes mellitus using two-dimensional speckle tracking echocardiography9
Mitochondrial mitophagy protection combining rivaroxaban and aspirin in high glucose-exposed human coronary artery endothelial cell. An in vitro study9
Shared and specific biological signalling pathways for diabetic retinopathy, peripheral neuropathy and nephropathy by high-throughput sequencing analysis9
Diabetic nephropathy ameliorated in patients with normal home blood pressure compared to those with isolated high home systolic blood pressure: A 5-year prospective cohort study among patients with ty8
Diabetes mellitus does not alter mortality or hospitalisation risk in patients with newly diagnosed heart failure with preserved ejection fraction: Time to rethink pathophysiological models of disease8
The triglyceride-glucose index and mortality in chronic kidney and cardiovascular disease patients: A cohort study8
Function outperforms morphology in the assessment of muscular contribution to insulin sensitivity in premenopausal women8
Subclinical myocardial dysfunction in normoglycemic first-degree relatives of patients with type 2 diabetes mellitus: Associations with Endothelin-1, E-selectin, and Endocan8
Visceral adipose tissue accumulation and risk of organ complications among individuals with type 2 diabetes mellitus: A two-sample Mendelian randomization study8
Glycemic control and outcome after carotid intervention in patients with T2D: A Swedish nationwide cohort study8
miR-1187 induces podocyte injury and diabetic nephropathy through autophagy7
US eligibility and preventable cardiovascular disease events from semaglutide in type 2 diabetes7
Early diagnosis value of lncRNA SNHG14 combined with miR-493-5p in gestational diabetes mellitus and its correlation with pregnancy outcome7
The association between sodium-glucose cotransporter 2 inhibitors and incident dementia: A nationwide population-based longitudinal cohort study6
A novel approach to diabetes-related foot ulcers/disease: First report of bipolar pulsed RF lumbar sympathetic block6
Glucose variability is associated with an adverse vascular profile but only in the presence of insulin resistance in individuals with type 1 diabetes: An observational study6
Letter to editor: Comments on “Early diagnosis value of lncRNA SNHG14 combined with miR-493-5p in gestational diabetes mellitus and its correlation with pregnancy outcome”6
A cross-sectional study exploring the relationship between oxidative balance score and 10-year atherosclerotic cardiovascular disease risk based on the National Health and Nutrition Examination Survey6
Real life evaluation of sodium-glucose cotransporter 2 inhibition in type 1 diabetes and the risk of diabetic ketoacidosis5
Impact of diabetes on long-term all-cause re-hospitalization after revascularization with percutaneous coronary intervention5
Ultra-high frequency ultrasound delineated changes in carotid and muscular artery intima-media and adventitia thickness in obese early middle-aged women5
Responses of retinal and brain microvasculature to streptozotocin induced diabetes revealed by global expression profiling5
Predictors of coronary artery calcium burden in asymptomatic patients with newly diagnosed type 2 diabetes mellitus5
Bioinformatics analyses of potential microRNAs and their target genes in myocardial infarction patients with diabetes5
Predictive power of isolated high home systolic blood pressure for cardiovascular outcomes in individuals with type 2 diabetes mellitus: KAMOGAWA-HBP study5
Patient-important outcomes in type 2 diabetes: The paradigm of the sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists5
Type 1 diabetes mellitus disease burden in high health expenditure countries between 1990 and 20194
A novel multi-omics–machine learning pipeline reveals immune and metabolic links between type 2 diabetes and atherosclerosis4
Associations of prognostic nutritional index with risk of all-cause and cardiovascular disease mortalities in persons with gestational diabetes mellitus: A NHANES-based analysis4
The impact of semaglutide on wound healing in diabetes related foot ulcer patients: A TriNetX database study4
Restoration of coronary microvascular function by OGA overexpression in a high-fat diet with low-dose streptozotocin-induced type 2 diabetic mice4
Combined effect of body mass index and atherogenic index of plasma on risk of stroke among individuals with abnormal glucose metabolism: Evidence from the China health and retirement longitudinal stud4
Impact of COVID-19 therapy on hyperglycemia4
Glycaemic variability and risk of adverse cardiovascular events in acute coronary syndrome4
Comparative prognostic value of hemoglobin glycation index and glycation gap for mortality risk in adults: A population-based study4
Cardiovascular risk factors, exercise capacity and health literacy in patients with chronic ischaemic heart disease and type 2 diabetes mellitus in Germany: Baseline characteristics of the Lifestyle I4
Mid-term safety and efficacy of magnesium bioresorbable vascular scaffolds – magmaris in diabetic population. 2-Years outcome in acute coronary syndrome cohort4
0.025982141494751